N-(cyclohexylmethyl)-N-[(3,4-dimethoxyphenyl)methyl]-2-piperidin-1-ylethanamine,dihydrochloride

Names

[ CAS No. ]:
102071-11-4

[ Name ]:
N-(cyclohexylmethyl)-N-[(3,4-dimethoxyphenyl)methyl]-2-piperidin-1-ylethanamine,dihydrochloride

[Synonym ]:
1-(2-((Cyclohexylmethyl)veratrylamino)ethyl)piperidine dihydrochloride
N-(cyclohexylmethyl)-N-[(3,4-dimethoxyphenyl)methyl]-2-piperidin-1-ylethanamine dihydrochloride
Piperidine,1-(2-((cyclohexylmethyl)veratrylamino)ethyl)-,dihydrochloride

Chemical & Physical Properties

[ Boiling Point ]:
477.5ºC at 760mmHg

[ Molecular Formula ]:
C23H40Cl2N2O2

[ Molecular Weight ]:
447.48200

[ Flash Point ]:
127ºC

[ Exact Mass ]:
446.24700

[ PSA ]:
24.94000

[ LogP ]:
6.11390

[ Vapour Pressure ]:
2.78E-09mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TM6623500
CHEMICAL NAME :
Piperidine, 1-(2-((cyclohexylmethyl)veratrylamino)ethyl)-, dihydrochloride
CAS REGISTRY NUMBER :
102071-11-4
LAST UPDATED :
198609
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C23-H38-N2-O2.2Cl-H
MOLECULAR WEIGHT :
447.55
WISWESSER LINE NOTATION :
T6NTJ A2N1R CO1 DO1&1- AL6TJ &GH 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
FRPSAX Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 15,562,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
FRPSAX Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 15,562,1960

Related Compounds

  • 4-(2,2,2-Trifluoroethoxy)-3-(trifluoromethyl)aniline
  • N-(3-chlorobenzyl)-2-(3-(furan-2-yl)-6-oxopyridazin-1(6H)-yl)acetamide
  • N-[(2Z)-4-tert-butyl-1,3-thiazol-2(3H)-ylidene]-2-[6-oxo-3-(thiophen-2-yl)pyridazin-1(6H)-yl]acetamide
  • 2-(3-(4-fluorophenyl)-6-oxopyridazin-1(6H)-yl)-N-(4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)acetamide
  • 2-(3-methylbutyl)-N-(1-methyl-1H-pyrazol-4-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide
  • 2-(3-methoxypropyl)-N-(1-methyl-1H-pyrazol-4-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide
  • N-(5-cyclobutyl-1,3,4-thiadiazol-2-yl)-2-(4-methoxyphenyl)acetamide
  • N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-2-methyl-1-oxo-1,2-dihydroisoquinoline-4-carboxamide
  • N-benzyl-2-(3-(4-(4-methoxyphenyl)piperazin-1-yl)-6-oxopyridazin-1(6H)-yl)-N-methylacetamide
  • N-[(2Z)-5-(2-methylpropyl)-1,3,4-thiadiazol-2(3H)-ylidene]-2-(2-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)acetamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.